2011
DOI: 10.4161/bbug.2.2.15009
|View full text |Cite
|
Sign up to set email alerts
|

Introducing a new Bioengineered Bug:Methylobacterium extorquenstuned as a microbial bioplastic factory

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 29 publications
0
8
0
2
Order By: Relevance
“…Examples of such biopolymers are the biodegradable polyesters polyhydroxybutyric acid (PHB) and polyhydroxyalkanoate (PHA). M. extorquens was genetically modified to increase PHB and PHA production using methanol as a substrate [ 116 ]. M. organophilum was also reported to accumulate PHB and PHA [ 117 ] under nitrogen limitation while biodegrading methane (a greenhouse gas).…”
Section: Biotechnological Uses Of Methylobacterium mentioning
confidence: 99%
“…Examples of such biopolymers are the biodegradable polyesters polyhydroxybutyric acid (PHB) and polyhydroxyalkanoate (PHA). M. extorquens was genetically modified to increase PHB and PHA production using methanol as a substrate [ 116 ]. M. organophilum was also reported to accumulate PHB and PHA [ 117 ] under nitrogen limitation while biodegrading methane (a greenhouse gas).…”
Section: Biotechnological Uses Of Methylobacterium mentioning
confidence: 99%
“…Insulin (Walsh, 2005); vanillin (Hansen et al, 2009; Brochado et al, 2010); antibodies such as penicillin (Kiel et al, 2005); and industrially valuable enzymes such as lipase (Pandey et al, 1999), cellulase (Kuhad et al, 2011), and amylase (Pandey et al, 2000) are already being produced in large scale with microbial factories. Apart from enzyme production, microbes are also being engineered to produce industrially important nanoparticles that are used in electronics and drug delivery (Dhanjal and Cameotra, 2010; Villaverde, 2010), environmentally beneficial bioplastics (Höfer et al, 2011), insect silk (Scheibel, 2004), opiates (Thodey et al, 2014), biofuels such as isobutanol (Desai et al, 2015), various chemicals (Vázquez et al, 2010), and proteins (Ferrer-Miralles et al, 2009). These industrial bioreactors are relatively inexpensive and efficient.…”
Section: Introductionmentioning
confidence: 99%
“…Potassium-limitation of Mtb organophilum had also been shown previously to enhance co-polyalkanoate formation (Kim et al 1999). Using both feeding with different n-alkenoic acids and genetic modification of a proprietary Methylobacterium strain could enable production of the ''functionalized'' polyhydroxyalkanoates required as advanced materials for tissue engineering, biocomposites, biodegradable polymers, and several medical uses (Höfer et al 2010(Höfer et al , 2011.…”
Section: Methylobacterium In Biotechnology and Biodeteriorationmentioning
confidence: 99%
“…Methylobacterium strains have been applied commercially to fermentation processes in the manufacture of coenzyme Q-10, lysine, tyrosine, phenylalanine, vitamin B12, enzymes, bioactive peptides, bio-insecticides, biopolymers such as polyb-hydroxybutyrate (PHB), and copolymeric polyalkanoates (Bormann et al 1997;Bourque et al 1995;Desmarteaux et al 2012;Green 2006;Höfer et al 2011;Kim et al 1999;Yezza et al 2006). Methylobacterium strains were never regarded as likely candidates for the commercial production of single-cell-protein as a foodstock, or for biosynthesis of deuterated and 13 C/ 15 Nlabeled ribonucleotides, as their growth yields (protein produced/mol methanol consumed) were inferior to those of methylotrophs such as Methylophilus methylotrophus, which used the Quayle cycle for C 1 -assimilation, rather than the serine pathway found in Methylobacterium (Batey et al 1996;Schrader et al 2009;Westlake 1986).…”
Section: Methylobacterium In Biotechnology and Biodeteriorationmentioning
confidence: 99%